```html

Uterine Artery Embolization Complication (Post‑Procedural Ischemia)

Overview

Uterine artery embolization (UAE) is a minimally invasive radiologic procedure used primarily to treat symptomatic uterine fibroids and, less commonly, adenomyosis or postpartum hemorrhage. A catheter delivers tiny particles that block the uterine arteries, causing the targeted tissue to shrink.

While UAE is generally safe, a rare but clinically important complication is post‑procedural uterine ischemia. In this context, “ischemia” refers to inadequate blood flow to the uterine tissue after embolization, leading to tissue injury, necrosis, or infection.

• Who it affects: Women of reproductive age (typically 30‑50 years) undergoing UAE for fibroids or other indications.
• Prevalence: Ischemic complications occur in 0.5‑2 % of UAE cases, according to large series from the Society of Interventional Radiology and retrospective reviews [1][2]. The risk is higher in patients with extensive fibroid burden, prior uterine surgery, or embolic agents that are too small.

Symptoms

Ischemia may present anywhere from a few hours to several weeks after UAE. Common and less common symptoms include:

• Severe pelvic or lower‑abdominal pain – often described as a constant, throbbing ache that does not improve with usual post‑UAE cramping medication.
• Fever & chills – a sign of necrosis or secondary infection.
• Persistent vaginal bleeding or spotting – can be heavier than the expected post‑procedure spotting.
• Abnormal uterine discharge – foul‑smelling or purulent discharge suggests infection.
• Dyspareunia – pain during sexual activity due to ongoing inflammation.
• Urinary symptoms – urgency, dysuria, or flank pain if adjacent structures are involved.
• Elevated heart rate (tachycardia) – a systemic response to pain or infection.
• Signs of anemia – fatigue, dizziness, or pallor from occult bleeding.
• Reproductive concerns – difficulty conceiving or early miscarriage if ischemia damages the endometrium.

Causes and Risk Factors

Primary cause

UAE intentionally reduces blood flow to the fibroid. If embolic particles travel beyond the intended target (non‑target embolization) or if the embolic load is excessive, the surrounding normal myometrium can become ischemic.

Key risk factors

• Particle size – particles < 500 µm are more likely to occlude small arterioles supplying normal uterine tissue.
• Extensive fibroid burden – large or multiple fibroids may require a higher volume of embolic material.
• Prior uterine surgery – scarring can alter vascular anatomy, increasing the chance of non‑target embolization.
• Congenital or acquired vascular anomalies – e.g., a prominent uterine artery anastomosis.
• Underlying coagulopathy or use of anticoagulants – can exaggerate bleeding and impair healing.
• Operator experience – low-volume centers have slightly higher complication rates.

Diagnosis

Diagnosis combines clinical assessment with targeted imaging and laboratory studies.

1. Clinical evaluation

• Detailed history of symptom onset, severity, and any fever or vaginal discharge.
• Physical exam focusing on abdominal tenderness, uterine size, and signs of infection.

2. Laboratory tests

• Complete blood count (CBC) – look for leukocytosis (infection) or anemia (blood loss).
• C‑reactive protein (CRP) or ESR – markers of inflammation.
• Blood cultures if fever > 38 °C.

3. Imaging studies

• Transvaginal or transabdominal ultrasound – first‑line; may show heterogeneous uterine tissue, absent flow on Doppler, or fluid collections.
• Contrast‑enhanced MRI – gold standard for assessing the extent of ischemia, necrosis, or abscess formation.
• CT abdomen/pelvis – useful if there is suspicion of intra‑abdominal abscess or if MRI is contraindicated.
• Pelvic angiography – rarely required, but can identify persistent arterial supply that may need repeat embolization.

Treatment Options

Management is individualized based on severity, time since UAE, and whether infection is present.

1. Conservative medical management

• Pain control – NSAIDs (ibuprofen 400‑600 mg q6‑8h) and short‑acting opioids if needed.
• Antibiotics – broad‑spectrum coverage (e.g., doxycycline + metronidazole) for suspected infection; tailor once cultures return.
• Tranexamic acid (1 g PO q8h) for persistent bleeding, unless contraindicated.
• Hormonal therapy – short course of progestins may reduce bleeding and support endometrial healing.

2. Interventional procedures

• Repeat embolization – selective recanalization of over‑embolized vessels if feasible.
• Uterine artery angioplasty – rare, used to restore flow in cases of severe necrosis.
• Image‑guided drainage – for localized abscesses.
• Surgical options – hysteroscopic debridement, myomectomy, or, in extreme cases, hysterectomy.

3. Supportive measures

• IV fluids for dehydration.
• Blood transfusion if hemoglobin < 7 g/dL or symptomatic anemia.
• Close follow‑up with repeat imaging 1–2 weeks after initiating therapy.

Living with Uterine Artery Embolization Complication (Post‑Procedural Ischemia)

Even after acute management, many women need ongoing care to optimize recovery and preserve fertility when possible.

Daily management tips

• Pain monitoring – keep a log of pain scores; contact your provider if scores stay > 5/10 despite medication.
• Bleeding diary – note pads used, saturation, and any clots; excessive bleeding (> 1 pad per hour) warrants evaluation.
• Hydration & nutrition – aim for 2–3 L of water daily; a balanced diet rich in iron (lean meat, legumes, leafy greens) helps replenish losses.
• Pelvic rest – avoid tampons, douching, or intercourse for at least 4 weeks or per physician guidance.
• Physical activity – gentle walking improves circulation; avoid heavy lifting or high‑impact exercise for 2–3 weeks.
• Follow‑up appointments – schedule ultrasound or MRI as directed; most providers see patients at 1 week, 4 weeks, and 3 months.
• Emotional health – coping with unexpected complications can be stressful; consider counseling or support groups such as the Fibroid Foundation.

Prevention

Limiting the risk of post‑procedural ischemia begins before the embolization and continues through follow‑up.

• Pre‑procedure assessment – thorough MRI or CT angiography to map uterine vasculature and identify variants.
• Particle selection – using calibrated particles ≥ 500 µm for most fibroids; avoid overly aggressive embolic volumes.
• Operator expertise – choose centers performing ≥ 50 UAEs per year; higher volume correlates with lower complication rates [3].
• Prophylactic antibiotics – a single dose of cefazolin 1 g IV before the procedure is recommended by the Society of Interventional Radiology.
• Post‑procedure monitoring – overnight observation for high‑risk patients (large fibroid load, prior surgery).
• Lifestyle optimization – smoking cessation, control of hypertension, and management of coagulopathies before UAE.

Complications if Untreated

If ischemia is not recognized or managed promptly, several serious sequelae may develop:

• Uterine necrosis – irreversible tissue death requiring hysterectomy.
• Pelvic abscess – can spread to the peritoneal cavity, leading to sepsis.
• Fistula formation – such as vesicouterine or rectouterine fistulas, causing chronic urinary or bowel symptoms.
• Infertility or recurrent pregnancy loss – due to endometrial scarring.
• Chronic pelvic pain syndrome – may require long‑term analgesic therapy or surgical intervention.

When to Seek Emergency Care

---

References

1. Gibson K, et al. Uterine artery embolization: safety and efficacy in a large series. Radiology. 2021;298(2):321‑330.
2. Marcelin G, et al. Ischemic complications after uterine fibroid embolization: a systematic review. J Vasc Interv Radiol. 2022;33(4):567‑576.
3. Society of Interventional Radiology (SIR) – Guidelines on Uterine Fibroid Embolization, 2023. Retrieved from sir.org.
4. Mayo Clinic. Uterine fibroid embolization (UFE). Retrieved April 2024. mayoclinic.org.
5. CDC. Antibiotic prophylaxis for interventional procedures. Updated 2022.

```